FREE SHIPPING FEDEX 2-DAY AIR SHIPPING ON ORDERS OVER $89.00!

OptiLight by Lumenis

In-Office Treatments / IPL

OptiLight by Lumenis: IPL for Dry Eye

OptiLight is an in-office light treatment for dry eye caused by meibomian gland dysfunction (MGD). It is the first and only intense pulsed light device cleared by the FDA for managing dry eye disease due to MGD, and a professional performs it alongside your other dry eye care. Here is how it works, who it suits, and what to expect.

Key Takeaways

  • OptiLight is an in-office intense pulsed light (IPL) treatment for dry eye driven by meibomian gland dysfunction (MGD).
  • It is the first and only IPL device cleared by the FDA for managing dry eye disease due to MGD, in adults 22 and older.
  • It works by calming inflammation, reducing abnormal blood vessels, supporting the oil glands, and lowering Demodex mites, which together help the tear film.
  • It is used alongside other care, such as warm compresses, lid hygiene, gland expression, and artificial tears, not as a standalone cure.
  • A typical course is about four short sessions, performed only by a trained eye care professional, with little downtime.
  • It is not right for everyone, so a doctor decides if you are a candidate. Use the locator to find a provider who offers it.

Quick Answer: what is OptiLight?

OptiLight by Lumenis is an in-office IPL treatment for dry eye caused by meibomian gland dysfunction. Pulses of light applied to the skin below the eyes help calm the inflammation behind MGD and support healthier oil glands and a more stable tear film. It is the only IPL device cleared by the FDA for dry eye management due to MGD, given as a series of short sessions by an eye care professional, alongside your other dry eye care. A doctor determines whether it is right for you.

What OptiLight Is

OptiLight is a light-based treatment made by Lumenis, the company that invented intense pulsed light. It uses the company's patented Optimal Pulse Technology to deliver controlled pulses of broad-spectrum light to the skin on the cheeks, just below the eyes. It is performed in an eye care office by a licensed professional, not something you do at home, and the eyes are fully shielded during treatment.

OptiLight is the first and only IPL device authorized by the FDA for improving the signs of dry eye disease due to meibomian gland dysfunction, in patients 22 and older. Source: Lumenis (OptiLight) and the device's FDA authorization.

How It Works

MGD and dry eye are tied closely to inflammation around the eyelids and oil glands. OptiLight targets that root problem in several ways at once. The light is thought to lower the inflammatory signals that drive dry eye, shrink the small abnormal blood vessels that feed that inflammation, support the structure and function of the oil glands, and reduce the population of Demodex mites that can irritate the lids. The aim is a calmer ocular surface and a more stable tear film.

In peer-reviewed studies of Lumenis IPL with its pulse technology, treatment was reported to lengthen tear breakup time and lower markers of inflammation. Source: Lumenis (OptiLight) and the cited clinical studies.

Who It Is For

In the United States, OptiLight is intended for adults 22 and older with moderate to severe dry eye due to MGD, and for lighter to medium skin tones (Fitzpatrick types I to IV). The light is applied only to the cheek area below the eyes, never on the eyes themselves. It is meant to be used together with your other care, such as gland expression, artificial tears, and warm compresses, rather than on its own.

OptiLight is not right for everyone. It is generally avoided if you have any of the following in the treatment area, so share your full history with your provider:

  • Eye surgery, eyelid surgery, or facial nerve weakness within the past six months.
  • Uncontrolled eye surface disease, or a recent eye infection.
  • Skin cancer, pre-cancerous spots, or pigmented lesions in the area.
  • Uncontrolled infections, or conditions that suppress the immune system.
  • A history of cold sores or rashes around the mouth, such as herpes simplex, or conditions like lupus or porphyria.
  • Use of light-sensitizing medications or herbs within the past three months.
  • Recent or planned radiation to the head or neck, or recent or planned chemotherapy.
  • A history of migraines, seizures, or epilepsy.

Only an eye care professional can confirm whether OptiLight is a safe and suitable option for you after an exam.

What to Expect

The treatment is quick and done in the office. Your provider shields your eyes, applies a thin layer of gel to the skin below your eyes, and delivers the light pulses across the cheek area.

Aspect What to expect
Number of sessions Usually about four, spaced a few weeks apart.
Session length Around 15 minutes each.
Area treated Skin on the cheeks below the eyes, with the eyes shielded.
Comfort A brief warm sensation as the light is applied; a cooling tip is used.
After treatment Possible mild redness that usually fades within a few hours.
Downtime Minimal; most people resume normal activities per their doctor's advice.

How Well It Works

The honest picture is encouraging but measured. Manufacturer-cited, peer-reviewed studies report longer tear breakup time and lower inflammation after a course of treatment. Independent reviews of the broader evidence see IPL as a helpful add-on for gland-related dry eye, with the strongest support for tear stability and less consistent effects on symptoms. In other words, OptiLight is best viewed as one tool used together with others, not a guaranteed or standalone fix.

Reviews of the wider evidence describe IPL as a useful adjunct for dry eye related to meibomian gland dysfunction, with benefits for tear stability and more variable effects on symptoms. Source: TFOS DEWS III Management and Therapy Report (2025).

Safety and Side Effects

When performed correctly by a trained professional, OptiLight is generally well tolerated. The most common effect is temporary redness or warmth in the treated area. Less commonly, IPL can cause discomfort, changes to skin texture or pigment, swelling, bruising, blistering or burns, itching, or dry skin. Serious effects are uncommon, and your eyes are fully protected during treatment. Talk with your provider about the full list of risks and whether they apply to you.

Dry Eye Rescue Tip

OptiLight supports your routine, it does not replace it. Keep up your warm compress, lid hygiene, and any drops your doctor recommends between sessions and after your course finishes. The glands respond best to steady care, and the in-office treatment works alongside it, not instead of it.

Find a Provider Who Offers OptiLight

OptiLight is only available through an eye care professional. Dry Eye Rescue works with a network of over 5,000 providers. Use the Doctor Locator to find one near you, or take the DryEye Q assessment to prepare for your visit.

DER

Medically reviewed by the DER Medical Advisory Panel

Dry Eye Rescue content is reviewed by the DER Medical Advisory Panel, a group of eye care professionals focused on dry eye and ocular surface care. Dry Eye Rescue helps patients shop trusted eye care products, learn about their condition, and locate a specialist.

Important Disclaimer

This page is educational and does not replace medical advice from your eye care professional. OptiLight is an in-office medical procedure that must be performed by a licensed professional, individual results vary, and only a doctor can determine whether it is appropriate for you. Talk with your provider about the full intended use, contraindications, and risks. OptiLight, Lumenis, and Optimal Pulse Technology (OPT) are trademarks of Lumenis Be Ltd. Dry Eye Rescue is not affiliated with, endorsed by, or sponsored by Lumenis, and connects patients with independent eye care professionals who may offer this treatment. Other product and brand names referenced on this site are trademarks of their respective owners.

Frequently Asked Questions

What is OptiLight?

It is an in-office intense pulsed light treatment for dry eye caused by meibomian gland dysfunction. Pulses of light applied below the eyes help calm inflammation and support the oil glands and tear film.

Is OptiLight FDA cleared?

Yes. It is the first and only IPL device authorized by the FDA for improving the signs of dry eye disease due to meibomian gland dysfunction, in adults 22 and older.

How does it help dry eye?

It targets the inflammation behind MGD, reduces abnormal blood vessels, supports the oil glands, and lowers Demodex mites. Together these can improve tear stability.

How many sessions will I need?

A typical course is about four sessions, spaced a few weeks apart, with each session taking around 15 minutes. Your provider sets the exact plan.

Does it hurt, and is there downtime?

Most people feel a brief warm sensation, and a cooling tip is used. Afterward you may have mild redness that usually fades within a few hours, with minimal downtime.

Who should not have OptiLight?

It is generally avoided with recent eye or facial surgery, certain skin conditions or lesions, active infections, some immune or photosensitivity issues, recent radiation or chemotherapy, and a history of migraines, seizures, or epilepsy. A doctor reviews your history to decide.

Is OptiLight a cure for dry eye?

No. It is used alongside your other care, not instead of it. Keeping up warm compresses, lid hygiene, and drops between and after sessions is part of getting the best result.

How much does it cost, and will insurance cover it?

Cost varies by office, and IPL for dry eye is often not covered by insurance. Ask the provider's office about pricing and your benefits before you start.

Where can I get OptiLight?

It is available only through an eye care professional. Use the Dry Eye Rescue Doctor Locator to find a provider near you who offers it.

See If OptiLight Is Right for You

OptiLight is offered by eye care professionals in our network. Find a provider near you, take the DryEye Q to prepare, or head back to all in-office treatments.